#ADCS
Daiichi Sankyo presenta en ESMO resultados destacados de tres ensayos clínicos en cáncer de mama y nuevos datos de sus anticuerpos conjugados

https://www.europesays.com/es/185624/

Daiichi Sankyo dará a conocer nuevos datos de sus anticuerpos conjugados (ADCs) DXd en el Congreso de la…
Daiichi Sankyo presenta en ESMO resultados destacados de tres ensayos clínicos en cáncer de mama y nuevos datos de sus anticuerpos conjugados - España
Daiichi Sankyo dará a conocer nuevos datos de sus anticuerpos conjugados (ADCs) DXd en el Congreso de la Sociedad Europea de Oncología Médica 2025 (#ESMO25),
www.europesays.com
October 18, 2025 at 7:28 PM Everybody can reply
#ESMO25: New evidence presented for #ADCs moving into the curative setting in #BreastCancer and #BladderCancer. Paolo Tarantino discusses the ‘unleashing’ of neoadjuvant and adjuvant ADC therapy to reduce recurrence and save lives
#ESMODailyReporter ➡️ https://ow.ly/vWqe50XeuTe

Paolo Tarantino, MD
October 18, 2025 at 4:30 PM Everybody can reply
💡 On again, off again, and now definitely on again! A mechanistic review on Antibody Drug Conjugates (ADCs) nature.com/articles/...
October 18, 2025 at 12:30 PM Everybody can reply
F5 Breach Analysis: When the Cobbler's Shoes Are Stolen The cybersecurity industry operates on trust. When a firm specializing in Application Delivery Controllers (ADCs), load balancing, and ne...

#Featured #Third-Party #Vendors #Original #Content #Data […]

[Original post on secureworld.io]
Original post on secureworld.io
www.secureworld.io
October 17, 2025 at 5:17 PM Everybody can reply
F5 Breach Analysis: When the Cobbler's Shoes Are Stolen The cybersecurity industry operates on trust. When a firm specializing in Application Delivery Controllers (ADCs), load balancing, and ne...

#Featured #Third-Party #Vendors #Original #Content #Data […]

[Original post on secureworld.io]
Original post on secureworld.io
www.secureworld.io
October 17, 2025 at 6:51 PM Everybody can reply
🎉 #ESMO25 begins today!
While I’m not attending in person, I’ll be following the talks closely from Shanghai.
Looking forward to insights on #PrecisionOncology, #Immunotherapy, #ADCs and more.
Let’s connect and share highlights!
#OncologyCommunity #CancerResearch
October 17, 2025 at 10:01 AM Everybody can reply
1 reposts 1 likes
#JGSO Agen |Invited Speaker

Glad to welcome Vijay CHUDASAMA (University College London, UK) for his talk:
🧪 Use of “click” chemistry and native disulfide rebridging to make homogeneous ADCs, bispecifics and “synthetic” antibodies (SynAbs)

📅 Nov 26 - 16:45 | Innovation in Drug Delivery Technologies
October 17, 2025 at 8:06 AM Everybody can reply
WO2025199666 hydrophilic carbohydrate-based multivalent linkers for antibody–drug conjugates (ADCs) enabling high, tunable DARs (up to 32) and dual-payload designs. They improve solubility, stability, pharmacokinetics, and efficacy, overcoming aggregation and heterogeneity limits.
[Credit: Canwell]
October 16, 2025 at 9:49 AM Everybody can reply
Another theory for low-cost ADCs: genuine parts acquired through bulk purchasing or regional pricing differences. This highlights the complexity of global component sourcing and its effect on manufacturing costs. #Procurement 5/6
October 15, 2025 at 10:00 PM Everybody can reply
The origins of cheap ADCs are debated: are they outright clones, remarked rejects that failed higher-spec tests, or even genuine parts from a different bin? Understanding the source impacts project risk and reliability. #SupplyChain 4/6
October 15, 2025 at 10:00 PM Everybody can reply
Beyond physical checks, performance testing is vital for ADCs. Focus on metrics like Effective Number of Bits (ENOB), noise characteristics, and reference voltage stability. Actual performance reveals true quality, not just datasheet claims. #ElectronicsTesting 3/6
October 15, 2025 at 10:00 PM Everybody can reply
Verifying cheap ADCs often involves physical inspection. Users discuss sanding down chips to examine the die or using acids to dissolve packaging to check for authentic markings. A critical step against counterfeits! #ComponentVerification 2/6
October 15, 2025 at 10:00 PM Everybody can reply
HN discussion on $2.97 ADCs: exploring their quality, origins (clones vs. genuine), and verification challenges. Debated methods to confirm authenticity & performance, plus implications for design & manufacturing due to price disparities. #HardwareHacks 1/6
October 15, 2025 at 10:00 PM Everybody can reply
or stage (first in class) with limited appetite for more incremental improvements or less differentiated assets that are very popular with investors (bispecifics, ADCs, radiopharma, half life extended biologics etc)
October 15, 2025 at 10:57 AM Everybody can reply
2 likes
And then that's it. The game is perfectly fine. I've been spamming MF on Brawl and gaping 90% over other ADCs that are seemingly too dumb to figure out how they can perform to impact the opposing team
October 15, 2025 at 10:20 AM Everybody can reply
Get a glimpse of #SIOG2025 Day 1 on Nov 20!
🧩 Workshops (ADCs, Geriatric Assessment, Implementation Science)
💬 #SPARC Roundtable on patient advocacy & inclusive care
🎉 25-Year Opening Celebration

🔗 See the programme https://loom.ly/bHFkxcc
🔗 Register https://loom.ly/wcc72oY
October 14, 2025 at 12:02 PM Everybody can reply
yeah guma should def stick to some of these other adcs like ashe bc his mf was so mediocre in comparison #worlds2025
October 14, 2025 at 11:42 AM Everybody can reply
W02025199464 describes anti-TROP2 antibody-drug conjugates (ADCs) using eribulin, a microtubule inhibitor, as payload. Targeting TROP2—an oncogenic driver of MAPK, PI3K-AKT, Wnt/β-catenin, and EMT pathways—these ADCs selectively kill TROP2⁺ tumors with reduced systemic toxicity.
[Credit: Eisai Co.]
October 14, 2025 at 10:40 AM Everybody can reply
1 likes
first gala with the corki, now guma with the MF.

these ADCs really love their bait picks #Worlds2025
October 14, 2025 at 9:16 AM Everybody can reply
1 quotes
📌 Exploiting DACL Permissions and ADCS ESC15 to Compromise Active Directory Domains https://www.cyberhub.blog/article/14346-exploiting-dacl-permissions-and-adcs-esc15-to-compromise-active-directory-domains
Exploiting DACL Permissions and ADCS ESC15 to Compromise Active Directory Domains
The article describes a sophisticated attack chain targeting Active Directory environments, leveraging Discretionary Access Control List (DACL) permissions and Active Directory Certificate Services (ADCS) exploits to compromise domain security. The attack begins with the restoration of a deleted object from the Active Directory Recycle Bin, which provides the attacker with a foothold to exploit DACL permissions. DACLs define access rights within Active Directory, and misconfigurations can grant attackers unintended privileges, facilitating lateral movement and privilege escalation. A critical component of this attack is the exploitation of ADCS through the ESC15 technique, which likely involves manipulating certificate templates or request processes to obtain certificates with elevated permissions, ultimately leading to domain compromise. The article mentions the use of Bloodhound, a popular tool for visualizing and analyzing attack paths in Active Directory, which helps attackers identify misconfigured permissions and potential paths for privilege escalation. Organizations must regularly audit DACL settings to ensure that permissions are correctly configured and that no unintended access rights are granted. The ability to restore deleted objects can be a double-edged sword, as it can also be exploited by attackers. Access to the Recycle Bin should be tightly controlled and monitored. ADCS is a frequent target for privilege escalation attacks, and organizations should review and secure certificate templates to ensure that only authorized users can request certificates with elevated privileges. While attackers use Bloodhound to identify attack paths, defenders can leverage it to proactively identify and remediate potential vulnerabilities in their Active Directory environments. This attack chain underscores the complexity and interconnectedness of Active Directory environments, highlighting the need for comprehensive monitoring, regular audits, and robust configuration management practices. Regular audits of DACL permissions and ADCS configurations are essential to identify and remediate potential vulnerabilities. Implementing strict access controls and monitoring for the Active Directory Recycle Bin can prevent unauthorized restorations. Ensuring that certificate templates are configured securely and that only authorized users can request certificates with elevated privileges is crucial. Using tools like Bloodhound defensively can help identify and mitigate attack paths before they can be exploited by attackers. In conclusion, this attack chain serves as a reminder of the critical importance of securing Active Directory environments. By understanding and addressing these vulnerabilities, organizations can better protect themselves against sophisticated attacks targeting their domain infrastructure.
www.cyberhub.blog
October 14, 2025 at 1:20 AM Everybody can reply